Page last updated: 2024-12-06

ethionine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

L-ethionine : An S-ethylhomocysteine that has S-configuration at the chiral centre. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID25674
CHEMBL ID203187
CHEBI ID4886
SCHEMBL ID8967
MeSH IDM0007870

Synonyms (61)

Synonym
s-ethyl-l-homocysteine
l-s-ethylhomocysteine
butyric acid, 2-amino-4-(ethylthio)-, l-
butanoic acid, 2-amino-4-(ethylthio)-, (s)-
ethionine (van)
(l)-ethionine
l-2-amino-4-(ethylthio)butyric acid
ccris 289
nsc 82393
butyric acid, 2-amino-4-(ethylene)-, l-
brn 1722528
einecs 235-966-4
hsdb 5080
nsc82393
l-ethionine
nsc-82393
l-homocysteine, s-ethyl-
NCGC00014018
13073-35-3
ethionine ,
l-ethionine, >=99% (tlc)
NCI97927
NCISTRUC1_000100
NCISTRUC2_000170
NCGC00097127-01
chebi:4886 ,
CHEMBL203187 ,
bdbm50179693
(s)-2-amino-4-(ethylthio)butanoic acid
2-amino-4-ethyl sulfanyl butyric acid
E0039
(2s)-2-amino-4-ethylsulfanylbutanoic acid
wx1bn24wzt ,
unii-wx1bn24wzt
CCG-36221
NCGC00014018-02
(2s)-2-amino-4-(ethylsulfanyl)butanoic acid
l-2-amino-4-(ethylthio)butanoic acid
(+)-ethionine
(+)-s-ethyl-l-homocysteine
homocysteine s-ethyl ether
ethionine [mi]
ethionine [hsdb]
SCHEMBL8967
GGLZPLKKBSSKCX-YFKPBYRVSA-N
2-amino-4-(ethylthio)butyric acid, (l)-
(l)-butyric acid, 2-amino-4-(ethylthio)-
mfcd00002626
DTXSID5020578
J-005868
l-ethionine, 98%
AS-58177
(s)-ethionine
Q5403506
h-eth-oh
A12005
AKOS016844009
nsc82393l-ethionine
A888677
(s)-2-amino-4-(ethylthio)butanoicacid
EN300-194573

Research Excerpts

Overview

L-Ethionine is an ethyl analogue of the amino acid, methionine, well known as a carcinogen but not as a mutagen. DL-ethionine (DLE) is an agent selectively toxic to the exocrine pancreas.

ExcerptReferenceRelevance
"Ethionine is a non-proteinogenic amino acid having similar chemical structure and activity to that of methionine, with which it competes."( Excessive apoptosis and ROS induced by ethionine affect neural cell viability and differentiation.
Khan, A; Li, D; Liu, X; Liu, Z; Mu, J; Niu, B; Wang, L; Xie, J; Xu, J; Yan, P; Zhang, J; Zhang, L, 2020
)
1.55
"L-Ethionine is an ethyl analogue of the amino acid, methionine, well known as a carcinogen but not as a mutagen. "( Effect of L-ethionine on spontaneous and MMC-induced SCEs in G0 and G1 human lymphocytes under liquid-holding recovery conditions.
De Salvia, R; Palitti, F; Perticone, P; Tanzarella, C, 1984
)
1.37
"DL-ethionine (DLE) is an agent selectively toxic to the exocrine pancreas."( DL-ethionine treatment of adult pancreatic donors. Amelioration of diabetes in multiple recipients withe tissue from a single donor.
Gorecki, P; Matas, AJ; Najarian, JS; Payne, WD; Sutherland, DE, 1979
)
1.39

Effects

ExcerptReferenceRelevance
"L-ethionine has been found to inhibit uracil tRNA methylating enzymes in vitro under conditions where methylation of other tRNA bases is unaffected. "( Selective inhibition of uracil tRNA methylases of E. coli by ethionine.
Tscherne, JS; Wainfan, E, 1978
)
1.22

Actions

Ethionine does not cause changes in the blood parameters, including total plasma iron-binding capacity and plasma iron clearance. Methionine thus promotes convulsions under certain conditions, plerhaps due to an accumulation of homocysteine or of other metabolites with convulsive properties.

ExcerptReferenceRelevance
"Methionine thus promotes convulsions under certain conditions, plerhaps due to an accumulation of homocysteine or of other metabolites with convulsive properties.U"( Production of convulsions in mice by the combination of methionine and homocysteine.
Freed, WJ; Gillin, JC; Luchins, DJ; Taylor, SP; Wyatt, RJ, 1980
)
1.13
"Ethionine was able to increase liver tRNA methylase activity in guinea pigs as well as rats, as previously described, but not in chicks."( Hepatocarcinogen-induced tRNA methylase activity in rat liver.
Forrester, PI; Hancock, RL, 1978
)
0.98
"2. Ethionine does not cause changes in the blood parameters, including total plasma iron-binding capacity and plasma iron clearance."( Plasma and tissue iron changes in the rat after acute administration of ethionine.
Archdeacon, JW; Loh, TT,
)
0.88
"Ethionine was found to increase the generation time of those cells already committed to cell division and to abolish the initiation of new cell cycles."( Effect of ethionine on the in vitro synthesis and degradation of mitochondrial translation products in yeast.
Basilio, C; George-Nascimento, C; Jacob, G; Téllez, R, 1985
)
1.39

Treatment

Ethionine and adenine treatment causes methyl deficiency of nuclear rRNA at 2'-hydroxyribose sites. Methionine treatment significantly affected progression of hepatic tumors induced by DL-ethionine administration.

ExcerptReferenceRelevance
"In ethionine-treated animals neutral fat was increased, whereas phospholipids and cholesterol were unchanged."( Studies on ethionine-induced fatty liver.
Caldarera, CM; Marchetti, M; Puddu, P, 1967
)
1.15
"The ethionine and adenine treatment causes methyl deficiency of nuclear rRNA at 2'-hydroxyribose sites of cytidine and uridine, but not at base sites."( Effect of ethionine on synthesis and methylation of ribosomal ribonucleic acid in regenerating rat liver.
Tsukada, K; Wen, LT, 1983
)
1.15
"Methionine treatment significantly affected progression of hepatic tumors induced by DL-ethionine administration."( The effect of methionine on the progression of hepatocellular carcinoma induced by ethionine.
Altman, NH; Brada, Z; Bulba, S; Hill, M, 1982
)
1.24
"Ethionine treatment decreased the rate of respiration, respiratory control ratio and P/O ratio."( Protective effect of vitamin E against ethionine toxicity.
Padma, P; Setty, OH, 1997
)
1.29
"Ethionine treated hepatocytes in suspension showed the same rate of triglyceride synthesis and transportation out of cells as control cells."( Ethionine toxicity in vitro: the correlation of data from rat hepatocyte suspensions and monolayers with in vivo observations.
Asker, DS; George, E; Murdock, JC; Timbrell, JA; Waterfield, CJ; Westmoreland, C, 1998
)
2.46
"In ethionine-treated rats, glucose infusion decreased hepatic cAMP content and phosphorylase activity and increased synthetase activity."( Effects of reduced ATP concent on hepatic responses to glucagon.
Craven, P; DeRubertis, FR, 1976
)
0.77
"When ethionine treatment was stopped, the acinar cells rapidly returned to their normal morphology."( Formation and fate of ethionine-induced cytoplasmic crystalloids in rat parotid acinar cells.
Auth, RE; Hand, AR; Oliver, C, 1979
)
1.03
"In ethionine-treated rat liver, ischemia brought about a further decrease in membrane potential without significant decrease in ATP content."( The relationship between membrane potential and ATP content in rat liver during ischemia.
Kanno, Y; Muneoka, Y; Shiba, Y, 1978
)
0.77
"Ethionine treatment greatly elevated the diene species (significant at the 0.005 level for 34:2 and 0.001 level for 36:2)."( Effects of ethionine and phenobarbital on the phosphatidylcholines of rat liver.
Dyer, RA; Klopfenstein, WE, 1977
)
1.37
"Ethionine treatment increased uridine triphosphate (UTP) and other UTP-derived nucleotides."( Effect of reduced hepatic energy state on acetaminophen conjugation in rats.
Dills, RL; Klaassen, CD, 1986
)
0.99
"In ethionine-treated rats, the ATP content of adipose tissue was not decreased whereas in liver it was drastically reduced to about one-fifth of the control level. "( Effect of ethionine on carbohydrate and lipid metabolism.
Itatsu, T; Ogata, K; Tani, H, 1973
)
1.28
"Treatment with ethionine and seleno-D,L-ethionine, two inhibitors known to have I50 values 50 to 60 times lower against SAMS purified from Novikoff hepatoma cells as compared with SAMS purified from normal rat liver, resulted in increased cell lysis in HepG2 and HuH-7 cells but not cultured rat hepatocytes."( Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance.
Cai, J; Hwang, JJ; Lu, SC; Stain, SC; Sun, WM, 1996
)
0.95
"Treatment with ethionine or fructose reduced the hepatic adenosine triphosphate/diphosphate ratio by 30 to 65% and 43 to 54% and the phosphorylation potential by 50 to 80 and 43%, respectively."( Effect of reduced hepatic energy state on acetaminophen conjugation in rats.
Dills, RL; Klaassen, CD, 1986
)
0.61
"Treatment with ethionine resulted in fatty liver, reduced ATP content of liver, and alterations in serum amino acid concentrations."( Induction of hyperphenylalaninemia in mice by ethionine and phenylalanine.
Gehrmann, J; Neuhoff, V; Schott, K, 1986
)
0.87
"Mice treated with ethionine (intraperitoneally, 5mg./day for 4 days or 10mg./day for 3 days) showed a profound loss of hepatic glycogen, a decrease of glycogen synthetase activity, a development of hypoglycaemia, a two- to five-fold increase in the activity of glucose 6-phosphate dehydrogenase but no change in 6-phosphogluconate dehydrogenase and an earlier manifestation of the solubilization of phosphorylase as compared with glycogen synthetase."( Stimulation of pentose phosphate pathway dehydrogenase enzyme activities in ethionine-treated mice.
Fishman, WH; Sie, HG, 1968
)
0.8

Toxicity

ExcerptReferenceRelevance
" CR-1409 completely abolished the adverse effects of hydrocortisone on pancreatitis."( Involvement of cholecystokinin receptors in the adverse effect of glucocorticoids on diet-induced necrotizing pancreatitis.
Gomez, G; Green, D; Rajaraman, S; Thompson, JC; Townsend, CM; Uchida, T, 1989
)
0.28
" Supplementation of the ethionine-containing diet with either choline or betaine ameliorated the growth depression, although neither compound was able to completely overcome the toxic effects of ethionine."( Amelioration of ethionine toxicity in the chick.
Baker, DH; Lowry, KR, 1987
)
0.93
"4% was toxic to rats, resulting in depressed growth and food intake, decreased blood hemoglobin levels and darkened and enlarged spleens."( Role of 3-ethylthiopropionate in ethionine metabolism and toxicity in rats.
Steele, RD, 1982
)
0.55
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36

Compound-Compound Interactions

ExcerptReferenceRelevance
"05%) combined with dietary choline deficiency was used to study changes in aldehyde dehydrogenase (ALDH) activity during hepatocarcinogenesis in male Sprague-Dawley rats."( Changes in aldehyde dehydrogenase occurring during rat hepatocarcinogenesis induced by ethionine combined with dietary choline deficiency.
Evces, S; Lindahl, R, 1986
)
0.49

Bioavailability

ExcerptReferenceRelevance
" Protein binding of PB was unchanged in ET-treated animals, but the extent of bioavailability of PB tended to increase."( Toxicokinetics of phenobarbital in rats with DL-ethionine-induced liver injury.
Fukushima, T; Kawai, Y; Kuwamura, Y; Noguchi, M; Tanaka, K, 1993
)
0.54

Dosage Studied

dl-Ethionine under appropriate conditions of time and dosage eliminated the adrenal protection induced by aromatics and also delayed the induction of menadione reductase. At lower dosage of the drug, the ethionine treatment is able to prevent the observed change of the glucose-6-phosphatase activity.

ExcerptRelevanceReference
" Further effect on the inhibition of DNA synthesis by these carcinogens was obtained by dose-response studies and its results indicated that there was a correlation between pancreatic carcinogens and the inhibition of DNA synthesis after partial pancreatectomy in rats."( Effect of chemical carcinogens on pancreatic DNA synthesis in vivo.
Denda, A; Kondo, H; Konishi, Y; Sunagawa, M; Takahashi, S, 1976
)
0.26
" At lower dosage of the drug, the ethionine treatment is able to prevent the observed change of the glucose-6-phosphatase activity but not that of the Mg2+-ATPase."( The effect of egg phospholipid administration upon liver enzymic activities during ethionine treatment.
Fratini, F; Montanini, I; Porcellati, G, 1976
)
0.76
" In the high dosage group depletions mainly of the branched-chain amino acids and lysine occurred in serum and brain, whereas the concentrations of methionine and tryptophan were increased."( Biochemical and developmental features of experimental phenylketonuria induced by L-ethionine in suckling rats.
Gehrmann, J; Neuhoff, V; Schott, K, 1989
)
0.7
" In the high dosage ethionine group, for instance, concentrations of Ala, Gly, Ser, Met, and Phe were increased whereas concentrations of Lys, Asp, and Pro were decreased."( Induction of hyperphenylalaninemia in mice by ethionine and phenylalanine.
Gehrmann, J; Neuhoff, V; Schott, K, 1986
)
0.85
" after dosing but showed a partial recovery at the 4hr."( Nicotinamide-adenine dinucleotides in acute liver injury induced by ethionine, and a comparison with the effects of salicylate.
Sawyer, BC; Slater, TF, 1966
)
0.48
"The morphologic effects of actinomycin D (ACTD) on normal and regenerating rat pancreas at three dosage levels were studied."( Pancreas acinar cell regeneration. IX. Effect of actinomycin D on microstructure.
Fitzgerald, PJ; Herman, L; Kobayashi, Y; Marsh, WH; Rosenstock, L; Sato, T; Yamaguchi, K, 1971
)
0.25
"The effect of actinomycin D (ACTD) at three dosage levels on the enzymatic activities of the normal rat pancreas was studied."( Pancreas acinar cell regeneration. X. Effect of actinomycin D on enzymatic activities.
Fitzgerald, PJ; Marsh, WH, 1971
)
0.25
" Changes in the distribution of ATP between the cell sap and the large-particle fraction were determined at intervals after rats had been dosed with various substances."( Liver adenosine triphosphate content and bile flow rate in the rat.
Delaney, VB; Slater, TF, 1970
)
0.25
" Lipid content is increased by ranitidine in livers of rats dosed with ethanol."( Effects of cimetidine and ranitidine on the "lipoperoxide" and lipid content of liver of rats treated with CCl4, colchicine, ethanol, ethionine and emetine.
Agostini, C; Di Segni, M, 1984
)
0.47
" AMD activity at 48 hr after dosing of PB in the ET-treated rats was increased in the same degree as that in the control (normal)."( Effects of phenobarbital on drug metabolizing enzyme activities and other biochemical parameters in rats with DL-ethionine-induced liver injury.
Fujitsuka, T; Honda, K; Kawai, Y; Noguchi, M, 1994
)
0.5
"As part of a wider metabonomic investigation into the early detection and discrimination of site-specific hepatotoxicity, male Sprague-Dawley rats were dosed with the model hepatotoxins allyl formate, ethionine and alpha-naphthylisothiocyanate (ANIT)."( An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria.
Charuel, C; Clayton, TA; Everett, JR; Hanton, G; Le Net, JL; Lindon, JC; Nicholson, JK; Provost, JP, 2003
)
0.51
" dl-Ethionine under appropriate conditions of time and dosage eliminated the adrenal protection induced by aromatics and also delayed the induction of menadione reductase while depressing the amount of this enzyme which was synthesized."( INDUCED PROTECTION OF ADRENAL CORTEX AGAINST 7,12-DIMETHYLBENZ(ALPHA)ANTHRACENE. INFLUENCE OF ETHIONINE. INDUCTION OF MENADIONE REDUCTASE. INCORPORATION OF THYMIDINE-H3.
FUKUNISHI, R; HUGGINS, C, 1964
)
1.02
" However, in the rats dosed with galactosamine hydrochloride, which showed highly variable amounts of liver damage at ca."( Hepatotoxin-induced hypertyrosinemia and its toxicological significance.
Charuel, C; Clayton, TA; Everett, JR; Hanton, G; Le Net, JL; Lindon, JC; Nicholson, JK; Provost, JP, 2007
)
0.34
" Depending on the intended indication and dosing regimen, PPL can delay or stop development of a compound in the drug discovery process."( Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential.
Gehlhaar, D; Greene, N; Johnson, TO; Pelletier, DJ; Tilloy-Ellul, A,
)
0.13
" A dose-response relationship was demonstrated between liver injury and expansion of Hedgehog-responsive progenitors."( Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice.
Choi, SS; Diehl, AM; Fleig, SV; Huang, J; Jung, Y; Omenetti, A; Sicklick, JK; VanDongen, HM; Yang, L, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antimetaboliteA substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
S-ethylhomocysteineA non-proteinogenic alpha-amino acid that is methionine in which the S-methyl group is replaced by an S-ethyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
S-adenosyl-L-methionine cycle II427

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Voltage-dependent calcium channel subunit alpha-2/delta-1Mus musculus (house mouse)Ki0.10240.10001.64665.4000AID261154
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID625295Drug Induced Liver Injury Prediction System (DILIps) validation dataset; compound DILI positive/negative as observed in Pfizer data2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID1133029Inhibition of L-type amino acid transporter-mediated [3H]-L-histidine uptake in mouse S37 cells assessed as residual activity at 5 mM after 2 mins by liquid scintillation counting analysis relative to control1978Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
Synthetic sulfur-containing amino acids. Inhibition of transport systems in S37 ascites tumor cells.
AID1133031Inhibition of A-type amino acid transporter-mediated [3H]-L-histidine uptake in mouse S37 cells assessed as residual activity at 5 mM after 2 mins by liquid scintillation counting analysis relative to control1978Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
Synthetic sulfur-containing amino acids. Inhibition of transport systems in S37 ascites tumor cells.
AID540235Phospholipidosis-negative literature compound
AID261154Displacement of [3H]L-leucine from alpha-2delta containing calcium channel in murine brain2006Bioorganic & medicinal chemistry letters, Mar-01, Volume: 16, Issue:5
Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID588208Literature-mined public compounds from Lowe et al phospholipidosis modelling dataset2010Molecular pharmaceutics, Oct-04, Volume: 7, Issue:5
Predicting phospholipidosis using machine learning.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,830)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901540 (84.15)18.7374
1990's143 (7.81)18.2507
2000's85 (4.64)29.6817
2010's52 (2.84)24.3611
2020's10 (0.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.63 (24.57)
Research Supply Index7.57 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index72.50 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (43.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.10%)5.53%
Reviews55 (2.84%)6.00%
Case Studies1 (0.05%)4.05%
Observational0 (0.00%)0.25%
Other1,879 (97.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]